Literature DB >> 1495892

The in situ acetylation of an immobilized human serum albumin chiral stationary phase for high-performance liquid chromatography in the examination of drug-protein binding phenomena.

T A Noctor1, I W Wainer.   

Abstract

The in situ modification of an immobilized human serum albumin (HSA) high-performance liquid chromatographic chiral stationary phase by p-nitrophenyl acetate is reported. This procedure, which is thought to affect primarily a single reactive tyrosine residue within the protein structure, influenced the chromatographic retention and enantioselectivity factors of a wide range of solutes. For certain solutes, increases in both capacity factor and chiral resolution were observed. Ultrafiltration studies on representative test solutes using free HSA, treated in a similar manner to the immobilized protein, gave similar results as the chromatographic observations, indicating that the latter effects are not artifactual results of immobilization. The effect of the modification of HSA on the binding behavior of drugs reportedly sharing the site predominantly affected by the derivatization, namely, the indole-benzodiazepine binding site, varied greatly. This observation suggests that the affected binding area is not a single, tightly structurally defined site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495892     DOI: 10.1023/a:1015884112039

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Structure of human serum albumin.

Authors:  D C Carter; X M He
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

2.  Acetylation of human serum albumin by p-nitrophenyl acetate.

Authors:  G E Means; M L Bender
Journal:  Biochemistry       Date:  1975-11-04       Impact factor: 3.162

3.  Use of a human serum albumin-based high-performance liquid chromatography chiral stationary phase for the investigation of protein binding: detection of the allosteric interaction between warfarin and benzodiazepine binding sites.

Authors:  E Domenici; C Bertucci; P Salvadori; I W Wainer
Journal:  J Pharm Sci       Date:  1991-02       Impact factor: 3.534

4.  The reactive tyrosine residue of human serum albumin: characterization of its reaction with diisopropylfluorophosphate.

Authors:  G E Means; H L Wu
Journal:  Arch Biochem Biophys       Date:  1979-05       Impact factor: 4.013

5.  Use of a human serum albumin-based stationary phase for high-performance liquid chromatography as a tool for the rapid determination of drug-plasma protein binding.

Authors:  T A Noctor; M J Diaz-Perez; I W Wainer
Journal:  J Pharm Sci       Date:  1993-06       Impact factor: 3.534

6.  Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis.

Authors:  B Honoré; R Brodersen
Journal:  Mol Pharmacol       Date:  1984-01       Impact factor: 4.436

Review 7.  Molecular aspects of ligand binding to serum albumin.

Authors:  U Kragh-Hansen
Journal:  Pharmacol Rev       Date:  1981-03       Impact factor: 25.468

8.  Immobilized serum albumin: rapid HPLC probe of stereoselective protein-binding interactions.

Authors:  E Domenici; C Bertucci; P Salvadori; S Motellier; I W Wainer
Journal:  Chirality       Date:  1990       Impact factor: 2.437

9.  A highly reactive tyrosine residue as part of the indole and benzodiazepine binding site of human serum albumin.

Authors:  K J Fehske; W E Müller; U Wollert
Journal:  Biochim Biophys Acta       Date:  1979-04-25

10.  Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.

Authors:  U Kragh-Hansen
Journal:  Mol Pharmacol       Date:  1988-08       Impact factor: 4.436

View more
  9 in total

Review 1.  Pharmaceutical and biomedical applications of affinity chromatography: recent trends and developments.

Authors:  David S Hage; Jeanethe A Anguizola; Cong Bi; Rong Li; Ryan Matsuda; Efthimia Papastavros; Erika Pfaunmiller; John Vargas; Xiwei Zheng
Journal:  J Pharm Biomed Anal       Date:  2012-01-14       Impact factor: 3.935

Review 2.  Analysis of solute-protein interactions and solute-solute competition by zonal elution affinity chromatography.

Authors:  Pingyang Tao; Saumen Poddar; Zuchen Sun; David S Hage; Jianzhong Chen
Journal:  Methods       Date:  2018-02-02       Impact factor: 3.608

Review 3.  Analysis of stereoselective drug interactions with serum proteins by high-performance affinity chromatography: A historical perspective.

Authors:  Zhao Li; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2017-01-11       Impact factor: 3.935

Review 4.  Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.

Authors:  David S Hage; Jeanethe Anguizola; Omar Barnaby; Abby Jackson; Michelle J Yoo; Efthimia Papastavros; Erika Pfaunmiller; Matt Sobansky; Zenghan Tong
Journal:  Curr Drug Metab       Date:  2011-05       Impact factor: 3.731

Review 5.  Analysis of Biological Interactions by Affinity Chromatography: Clinical and Pharmaceutical Applications.

Authors:  David S Hage
Journal:  Clin Chem       Date:  2017-04-10       Impact factor: 8.327

Review 6.  Studies of metabolite-protein interactions: a review.

Authors:  Ryan Matsuda; Cong Bi; Jeanethe Anguizola; Matthew Sobansky; Elliott Rodriguez; John Vargas Badilla; Xiwei Zheng; Benjamin Hage; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-11-25       Impact factor: 3.205

Review 7.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

Review 8.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

9.  Rapid screening of drug-protein binding using high-performance affinity chromatography with columns containing immobilized human serum albumin.

Authors:  Ying-Fei Li; Xiao-Qiong Zhang; Wei-Yu Hu; Zheng Li; Ping-Xia Liu; Zhen-Qing Zhang
Journal:  J Anal Methods Chem       Date:  2013-03-28       Impact factor: 2.193

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.